In summary, our study demonstrates that local administration of recombinant GM-CSF can improve the immune response to the diphtheria-component in a multivalent tetanus and diphtheria toxoid containing vaccine, while the response to the tetanus-component remains unaltered. Here, CSF2 is linked to diphtheria.